This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
2016 Future Horizons and Growth Strategies in the German Enteric Diseases Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Future Horizons and Growth Strategies in the German Enteric Diseases Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
2015 Global Diagnostic Imaging Product Portfolio Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Diagnostic Imaging Product Portfolio industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report ...
November 2015 | $2850 | View Details >>
New Frontiers in Italian Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape is a new study designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian hematology and flow cytometry markets during the next five years. The report explores ...
November 2014 | $3900 | View Details >>
Immunodiagnostics 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests-Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers
Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new report is a strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), ...
March 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research